相关实验视频

Updated: Jun 16, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

在抗PD-1单疗治疗期间,粘膜黑色素瘤的超级进展占主导地位

Li Zhou¹, Min Cao², Haibin Zhu²

¹Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, People's Republic of China.

|August 20, 2024

概括

超渐进性疾病 (HPD) 影响了少数接受抗PD-1治疗的晚期黑色素瘤患者. 带有多种转移的粘膜黑色素瘤是一种普遍的亚型,需要对这种治疗保持谨慎.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
黑色素瘤研究黑色素瘤研究

背景情况:

接受免疫治疗的部分患者会发展出超渐进性疾病 (HPD).
黑色素瘤亚型之间HPD发病率的差异没有得到充分记录.
了解HPD对于优化黑色素瘤中抗PD-1单一治疗至关重要.

研究的目的:

为了确定晚期黑色素瘤患者中HPD的发病率和预后,这些患者接受了抗PD-1单一治疗.
在不同黑色素瘤亚型中识别与HPD相关的临床特征.
为了为临床决策提供有关黑色素瘤抗PD-1治疗的信息.

主要方法:

在临床试验中的262名晚期黑色素瘤患者中,使用四个既定定义评估了HPD发生率.
对比了不同HPD定义的预后能力.
分析了HPD患者的黑色素瘤亚型和临床特征与传统进展.

主要成果:

根据定义,HPD的发病率各不相同 (10.8%28.2%).
德尔塔TGR>100定义最好预测较差的整体存活率.
多个转移性器官 (>2) 和粘膜黑色素瘤被确定为HPD的危险因素.

结论:

德尔塔TGR>100是识别HPD在先进黑色素瘤患者在抗PD-1单疗中的最有效的定义.
具有多个转移部位的粘膜黑色素瘤患者显示HPD的患病率较高.
临床医生在粘膜黑色素瘤中使用抗PD-1单疗时应谨慎使用,这是由于HPD风险.

关键词:

超级进展是一种超级进展.免疫疗法免疫疗法黑色素瘤是一种黑色素瘤.

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...